Cognitive deficits in neurofibromatosis 1. (Q34982054)

5 August 2017

1 reference

title

Cognitive deficits in neurofibromatosis 1. (English)

1 reference

5 August 2017

Kathryn North

1

0 references

author name string

Shelley Hyman

series ordinal

2

1 reference

PubMed ID

12403559

5 August 2017

Belinda Barton

series ordinal

3

1 reference

5 August 2017

1 August 2002

1 reference

Journal of Child Neurology

5 August 2017

1 reference

5 August 2017

17

1 reference

5 August 2017

8

1 reference

5 August 2017

605-12; discussion 627-9, 646-51

1 reference

Neurofibromin in the brain

5 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Neurofibromatosis type 1: the cognitive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Intellectual impairment in neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Learning disability subtypes in children with neurofibromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Neuropsychological deficits in adults with neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Behavioral phenotype of neurofibromatosis, type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Neuropsychological profile of children with neurofibromatosis, brain tumor, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropathological study of 22 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Lesions of skin and brain: modern imaging of the neurocutaneous syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Evolution of white matter lesions in neurofibromatosis type 1: MR findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

The significance of MRI abnormalities in children with neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

COGNITIVE FUNCTION AND ACADEMIC PERFORMANCE IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380201700811

10.1177/088307380201700811

21 January 2018

Identifiers

DOI

0 references

Fatcat ID

release_3psjszimjncijje4ib4o4cn6ni

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3psjszimjncijje4ib4o4cn6ni

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12403559

1 reference

PubMed ID

12403559